Literature DB >> 26190042

[Introduction of the Screening Tool OncoFunction for Functional Follow-up of Head and Neck Patients].

V Zebralla1, N Pohle2, S Singer3, T Neumuth4, A Dietz5, M Stier-Jarmer6, A Boehm2.   

Abstract

INTRODUCTION: The follow-up for head and neck cancer (HNC) focussed on therapy control. Accessory long term functionality is important. Impairment of function is observed, but a comparable documentation is not established. Additional we frequently see psychooncological comorbidities, what complicates the assessment. This was the reason why Tschiesner et al. developed on the base of the "ICF Core set for head and neck cancer" a guideline for the Assessment of Function in HNC. In consequence of good results in other tumour entities we developed an electronic version (OncoFunction).
METHODS: In a proof of concept study all patients of our follow up consultation from 07/13 to 03/14 were included. OncoFunction was given to patients in a digital form using tablet computers. The results were visible to the physician in a concentrated form before consultation and were supplemented by a physician questionnaire. Furthermore we evaluated the usability in 202 patients.
RESULTS: We had 682 patient contacts. 530 patient contacts (77, 7%) used the questionnaire. The physician questionnaire was answered in 470 times. Finally there are from 69.8% of the patient contacts full datasets available. Between users and non-users of the questionnaire we see no difference.
CONCLUSION: The use of a computer-based screening and feedback system (OncoFunction) in clinical use is feasible and excellent assessed by patients. The patient data are visible in a compact form for the physician and problems can clear addressed to the patient. One more benefit is the standardized follow up documentation and the use of comparable data in research. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2015        PMID: 26190042     DOI: 10.1055/s-0035-1549858

Source DB:  PubMed          Journal:  Laryngorhinootologie        ISSN: 0935-8943            Impact factor:   1.057


  5 in total

Review 1.  Monitoring and Evaluation of Late Functional Outcome in Post-treatment Follow-Up in Clinical Routine Setting.

Authors:  Veit Zebralla; Sylvia Meuret; Susanne Wiegand
Journal:  Front Oncol       Date:  2019-07-30       Impact factor: 6.244

2.  Depression, anxiety, fatigue, and quality of life in a large sample of patients suffering from head and neck cancer in comparison with the general population.

Authors:  S Wiegand; V Zebralla; C Hammermüller; A Hinz; A Dietz; G Wichmann; M Pirlich; T Berger; K Zimmermann; T Neumuth; A Mehnert-Theuerkauf
Journal:  BMC Cancer       Date:  2021-01-22       Impact factor: 4.430

3.  Obtaining Patient-Reported Outcomes Electronically With "OncoFunction" in Head and Neck Cancer Patients During Aftercare.

Authors:  Veit Zebralla; Juliane Müller; Theresa Wald; Andreas Boehm; Gunnar Wichmann; Thomas Berger; Klemens Birnbaum; Katharina Heuermann; Steffen Oeltze-Jafra; Thomas Neumuth; Susanne Singer; Matthias Büttner; Andreas Dietz; Susanne Wiegand
Journal:  Front Oncol       Date:  2020-11-25       Impact factor: 6.244

4.  Web-Based Patient-Reported Outcomes for ENT Patients-Evaluation of the Status Quo, Patients' View, and Future Perspectives.

Authors:  Theresa Wald; Veit Zebralla; Maren Boege; Viktor Kunz; Thomas Neumuth; Andreas Dietz; Gunnar Wichmann; Susanne Wiegand
Journal:  Int J Environ Res Public Health       Date:  2022-09-18       Impact factor: 4.614

5.  Dysphagia, voice problems, and pain in head and neck cancer patients.

Authors:  Andreas Hinz; Susanne Wiegand; Veit Zebralla; Gunnar Wichmann; Markus Pirlich; Carola Hammermüller; Thomas Berger; Klara Zimmermann; Thomas Neumuth; Anja Mehnert-Theuerkauf; Andreas Dietz
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-01-16       Impact factor: 2.503

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.